Daniel E. Nixon

4.4k total citations · 3 hit papers
32 papers, 3.3k citations indexed

About

Daniel E. Nixon is a scholar working on Epidemiology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Daniel E. Nixon has authored 32 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 13 papers in Infectious Diseases and 11 papers in Emergency Medicine. Recurrent topics in Daniel E. Nixon's work include Cytomegalovirus and herpesvirus research (11 papers), HIV-related health complications and treatments (11 papers) and HIV Research and Treatment (10 papers). Daniel E. Nixon is often cited by papers focused on Cytomegalovirus and herpesvirus research (11 papers), HIV-related health complications and treatments (11 papers) and HIV Research and Treatment (10 papers). Daniel E. Nixon collaborates with scholars based in United States, Australia and Denmark. Daniel E. Nixon's co-authors include James D. Neaton, Russell P. Tracy, Waldo Belloso, Jens Lundgren, Jacqueline Neuhaus, Bruno Ledergerber, Lewis H. Kuller, Nicholas I. Paton, H. Clifford Lane and Fraser Drummond and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Daniel E. Nixon

31 papers receiving 3.3k citations

Hit Papers

Inflammatory and Coagulation Biomarkers and Mortality in ... 2008 2026 2014 2020 2008 2011 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
    2008 1.2k citations Lewis H. Kuller, Russell P. Tracy et al. PLoS Medicine profile →
  2. Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
    2011 856 citations Netanya G. Sandler, Handan Wand et al. The Journal of Infectious Diseases profile →
  3. Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
    2012 419 citations Daniel Duprez, Jacqueline Neuhaus et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Nixon United States 18 2.0k 1.7k 1.6k 1.0k 480 32 3.3k
Gilbert R. Kaufmann Australia 24 1.4k 0.7× 2.2k 1.3× 2.3k 1.4× 755 0.7× 494 1.0× 46 3.4k
P. Mercié France 31 1.2k 0.6× 889 0.5× 1.4k 0.9× 619 0.6× 175 0.4× 122 2.9k
Nicholas I. Paton United Kingdom 18 1.7k 0.8× 1.4k 0.8× 1.4k 0.9× 493 0.5× 256 0.5× 39 2.7k
Adam Rupert United States 25 852 0.4× 956 0.6× 891 0.6× 603 0.6× 464 1.0× 66 2.1k
E. McKinnon Australia 25 1.2k 0.6× 1.1k 0.7× 1.3k 0.8× 717 0.7× 505 1.1× 90 2.9k
Fraser Drummond Australia 11 1.5k 0.8× 1.1k 0.7× 1.2k 0.8× 508 0.5× 225 0.5× 18 2.2k
Stéphane De Wit Belgium 31 3.0k 1.5× 1.4k 0.8× 2.5k 1.6× 1.1k 1.1× 141 0.3× 98 4.3k
Leonardo Calza Italy 30 1.4k 0.7× 882 0.5× 1.6k 1.0× 578 0.6× 110 0.2× 197 2.7k
Fabrice Bonnet France 38 1.4k 0.7× 1.1k 0.6× 2.1k 1.3× 1.5k 1.5× 254 0.5× 173 4.4k
Philippe Morlat France 33 1.5k 0.8× 1.0k 0.6× 2.1k 1.3× 1.8k 1.7× 171 0.4× 109 4.2k

Countries citing papers authored by Daniel E. Nixon

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Nixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Nixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Nixon more than expected).

Fields of papers citing papers by Daniel E. Nixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Nixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Nixon. The network helps show where Daniel E. Nixon may publish in the future.

Co-authorship network of co-authors of Daniel E. Nixon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Nixon. A scholar is included among the top collaborators of Daniel E. Nixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Nixon. Daniel E. Nixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelvin, Elizabeth A., Bassam Dahman, Gavin George, et al.. (2024). The economic costs and cost-effectiveness of HIV self-testing among truck drivers in Kenya. Health Policy and Planning. 39(4). 355–362. 4 indexed citations
2.
Kimmel, April D., Rose S. Bono, Faye Z. Belgrave, et al.. (2024). Drive time to care and retention in HIV care: Rural–urban differences among Medicaid enrollees in the United States South. The Journal of Rural Health. 41(1). e12877–e12877.
3.
Dahman, Bassam, Rose S. Bono, Lindsay M. Sabik, et al.. (2022). Brief Report: Physician Reimbursement and Retention in HIV Care: Racial Disparities in the US South. JAIDS Journal of Acquired Immune Deficiency Syndromes. 92(1). 1–5. 1 indexed citations
4.
Levi, Laura, Shweta Sharma, Mark R. Schleiss, et al.. (2022). Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy. AIDS. 36(9). 1265–1272. 7 indexed citations
5.
Bryson, Alexandra, et al.. (2021). 669. Metagenomic Plasma Microbial Cell Free DNA-Sequencing Assists in Diagnosis of Infections and Critical Antimicrobial Changes in Immunocompromised Hosts. Open Forum Infectious Diseases. 8(Supplement_1). S437–S437. 1 indexed citations
6.
Collins, Gary S., Jason V. Baker, Daniel E. Nixon, et al.. (2018). Associations between baseline biomarkers and lung function in HIV-positive individuals. AIDS. 33(4). 655–664. 11 indexed citations
7.
Sauer, Anne, Daniel E. Nixon, Christine Murphy, et al.. (2018). A Guinea pig cytomegalovirus resistant to the DNA maturation inhibitor BDCRB. Antiviral Research. 154. 44–50. 2 indexed citations
8.
Hall, C. E., Vishal N. Kopardé, Myrna G. Serrano, et al.. (2017). Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity. PLoS ONE. 12(8). e0178763–e0178763. 13 indexed citations
9.
10.
Adler, Stuart P., Michael A. McVoy, Daniel E. Nixon, et al.. (2016). A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus–Seronegative Men. The Journal of Infectious Diseases. 214(9). 1341–1348. 46 indexed citations
11.
12.
Duprez, Daniel, Jacqueline Neuhaus, Lewis H. Kuller, et al.. (2012). Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals. PLoS ONE. 7(9). e44454–e44454. 419 indexed citations breakdown →
13.
Baker, Jason V., Jacqueline Neuhaus, Daniel Duprez, et al.. (2012). HIV Replication, Inflammation, and the Effect of Starting Antiretroviral Therapy on Plasma Asymmetric Dimethylarginine, a Novel Marker of Endothelial Dysfunction. JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(2). 128–134. 20 indexed citations
14.
Sandler, Netanya G., Handan Wand, Annelys Roque, et al.. (2011). Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection. The Journal of Infectious Diseases. 203(6). 780–790. 856 indexed citations breakdown →
15.
Baker, Jason V., Jacqueline Neuhaus, Daniel Duprez, et al.. (2010). Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(1). 36–43. 125 indexed citations
16.
Nixon, Daniel E. & Alan Landay. (2010). Biomarkers of immune dysfunction in HIV. Current Opinion in HIV and AIDS. 5(6). 498–503. 166 indexed citations
17.
Kuller, Lewis H., Russell P. Tracy, Waldo Belloso, et al.. (2008). Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLoS Medicine. 5(10). e203–e203. 1231 indexed citations breakdown →
18.
Lifson, Alan R., Waldo Belloso, Richard T. Davey, et al.. (2008). Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials. HIV Clinical Trials. 9(3). 177–185. 44 indexed citations
19.
Sterling, Richard K., et al.. (2007). The Prevalence and Risk Factors for Abnormal Liver Enzymes in HIV-Positive Patients without Hepatitis B or C Coinfections. Digestive Diseases and Sciences. 53(5). 1375–1382. 62 indexed citations
20.
Wang, Cunlin, Saba W. Masho, & Daniel E. Nixon. (2006). When to start antiretroviral therapy. Current HIV/AIDS Reports. 3(2). 66–73. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilbert R. Kaufmann Breakdown of academic impact, for papers by P. Mercié Breakdown of academic impact, for papers by Nicholas I. Paton Breakdown of academic impact, for papers by Adam Rupert Breakdown of academic impact, for papers by E. McKinnon Breakdown of academic impact, for papers by Fraser Drummond Breakdown of academic impact, for papers by Stéphane De Wit Breakdown of academic impact, for papers by Leonardo Calza Breakdown of academic impact, for papers by Fabrice Bonnet Breakdown of academic impact, for papers by Philippe Morlat
Rankless by CCL
2026